Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-26 05:27:01 UTC |
---|
Update Date | 2016-11-09 01:21:14 UTC |
---|
Accession Number | CHEM035052 |
---|
Identification |
---|
Common Name | Inositol 1,3,4,5-tetraphosphate |
---|
Class | Small Molecule |
---|
Description | Inositol 1,3,4,5-tetraphosphate, also known as inositol 1,3,4,5-tetraphosphate, belongs to the class of organic compounds known as inositol phosphates. Inositol phosphates are compounds containing a phosphate group attached to an inositol (or cyclohexanehexol) moiety. Inositol 1,3,4,5-tetraphosphate is possibly soluble (in water) and an extremely strong acidic compound (based on its pKa). Inositol 1,3,4,5-tetraphosphate participates in a number of enzymatic reactions, within cattle. In particular, Inositol 1,3,4,5-tetraphosphate can be converted into inositol 1,4,5-trisphosphate through its interaction with the enzyme multiple inositol polyphosphate phosphatase 1. In addition, Inositol 1,3,4,5-tetraphosphate can be biosynthesized from inositol 1,4,5-trisphosphate through its interaction with the enzyme inositol-trisphosphate 3-kinase a. In cattle, inositol 1,3,4,5-tetraphosphate is involved in the metabolic pathway called the inositol metabolism pathway. |
---|
Contaminant Sources | |
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
Inositol 1,3,4,5-tetraphosphoric acid | Generator | 1,3,4,5-Tetrakis(dihydrogen phosphate) myo-inositol | HMDB | 1D-Myo-inositol 1,3,4,5-tetrakis(dihydrogen phosphate) | HMDB | 1D-Myo-inositol 1,3,4,5-tetrakisphosphate | HMDB | D-Myo-inositol 1,3,4,5-tetrakisphosphate | HMDB | Inositol 1,3,4,5-tetrakis(phosphate) | HMDB | Inositol 1,3,4,5-tetrakisphosphate | HMDB | Inositol-(1,3,4,5)-tetrakisphosphate | HMDB | Inositol-1,3,4,5-tetrakisphosphate | HMDB | Inositol-1,3,4,5-tetraphosphate | HMDB | Ins-1,3,4,5-P4 | HMDB | Myo-inositol 1,3,4,5-tetrakis(phosphate) | HMDB | Myo-inositol 1,3,4,5-tetraphosphate | HMDB | Myo-inositol, 1,3,4,5-tetrakis(dihydrogen phosphate) | HMDB | Myo-inositol-1,3,4,5-tetrakisphosphate | HMDB | [(2R,3S,5S,6S)-3,5-Dihydroxy-2,4,6-triphosphonooxycyclohexyl] dihydrogen phosphate | HMDB | Inositol-1,3,4,5-tetrakisphosphate, DL-isomer | HMDB | Ins(1,3,4,5)p(4) | HMDB | Inositol-1,3,4,5-tetrakisphosphate, D-isomer | HMDB | Ins(1,3,4,5)P4 | HMDB |
|
---|
Chemical Formula | C6H16O18P4 |
---|
Average Molecular Mass | 500.076 g/mol |
---|
Monoisotopic Mass | 499.929 g/mol |
---|
CAS Registry Number | 102850-29-3 |
---|
IUPAC Name | {[(1R,2S,4S,5S)-2,4-dihydroxy-3,5,6-tris(phosphonooxy)cyclohexyl]oxy}phosphonic acid |
---|
Traditional Name | [(1R,2S,4S,5S)-2,4-dihydroxy-3,5,6-tris(phosphonooxy)cyclohexyl]oxyphosphonic acid |
---|
SMILES | O[C@H]1C(OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)C(OP(O)(O)=O)[C@H]1OP(O)(O)=O |
---|
InChI Identifier | InChI=1S/C6H16O18P4/c7-1-3(21-25(9,10)11)2(8)5(23-27(15,16)17)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/t1-,2-,3?,4-,5+,6?/m0/s1 |
---|
InChI Key | CIPFCGZLFXVXBG-FTSGZOCFSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as inositol phosphates. Inositol phosphates are compounds containing a phosphate group attached to an inositol (or cyclohexanehexol) moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Alcohols and polyols |
---|
Direct Parent | Inositol phosphates |
---|
Alternative Parents | |
---|
Substituents | - Inositol phosphate
- Monoalkyl phosphate
- Cyclohexanol
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Secondary alcohol
- Organic oxide
- Hydrocarbon derivative
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-9044600000-4ba1d39a2376ae51990f | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (2 TMS) - 70eV, Positive | splash10-0002-9512283000-844a1cfa75b9b1a00131 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0udi-4000960000-9b59d5f2f68eced6c6b2 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0f89-3000920000-35336854e899445bf318 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0pba-2009000000-b8ea1ab89bef94a720ff | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0002-3000900000-e06370a5540312cdccac | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-9002200000-067fbe6f368eb447aafe | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-004i-9000000000-33a9ca9001b179c65cdf | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | HMDB0001059 |
---|
FooDB ID | FDB022398 |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | 37244 |
---|
BioCyc ID | Not Available |
---|
METLIN ID | 5973 |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
Chemspider ID | 96919 |
---|
ChEBI ID | 16783 |
---|
PubChem Compound ID | 107758 |
---|
Kegg Compound ID | C01272 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | 1. DeSolms, S. Jane; Vacca, Joseph P.; Huff, Joel R. The total synthesis of (±)-myo-inositol-1,3,4-triphosphate, (±)-myo-inositol-2,4,5-triphosphate and (±)-myo-inositol-1,3,4,5-tetraphosphate. Tetrahedron Letters (1987), 28(39), 4503-6. | 2. Cozier GE, Lockyer PJ, Reynolds JS, Kupzig S, Bottomley JR, Millard TH, Banting G, Cullen PJ: GAP1IP4BP contains a novel group I pleckstrin homology domain that directs constitutive plasma membrane association. J Biol Chem. 2000 Sep 8;275(36):28261-8. | 3. Horne G, Potter BV: Synthesis of the enantiomers of 6-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, structural analogues of myo-inositol 1,3,4,5-tetrakisphosphate. Chemistry. 2001 Jan 5;7(1):80-7. | 4. Han SY, Kato H, Kato S, Suzuki T, Shibata H, Ishii S, Shiiba K, Matsuno S, Kanamaru R, Ishioka C: Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay. Cancer Res. 2000 Jun 15;60(12):3147-51. | 5. Xia HJ, Yang G: Inositol 1,4,5-trisphosphate 3-kinases: functions and regulations. Cell Res. 2005 Feb;15(2):83-91. | 6. Pouillon V, Hascakova-Bartova R, Pajak B, Adam E, Bex F, Dewaste V, Van Lint C, Leo O, Erneux C, Schurmans S: Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development. Nat Immunol. 2003 Nov;4(11):1136-43. Epub 2003 Sep 28. |
|
---|